Cargando…

SG-APSIC1027: COVID-19 vaccination strategy in Singapore—Perspectives and lessons from primary care

Objectives: The disruptions wrought by COVID-19 have spurred the development of vaccines at a pace unprecedented in global history. We have witnessed vaccine development from in vivo testing to population-wide implementation in just under 1 year. Singapore’s vaccination rate of 80%, attained at the...

Descripción completa

Detalles Bibliográficos
Autores principales: Koh, Sky Wei Chee, Keong, Victor Loh Weng, Yiyang, Liow, Kit, Leong Choon, Young, Doris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571223/
http://dx.doi.org/10.1017/ash.2023.26
_version_ 1785119940130373632
author Koh, Sky Wei Chee
Keong, Victor Loh Weng
Yiyang, Liow
Kit, Leong Choon
Young, Doris
author_facet Koh, Sky Wei Chee
Keong, Victor Loh Weng
Yiyang, Liow
Kit, Leong Choon
Young, Doris
author_sort Koh, Sky Wei Chee
collection PubMed
description Objectives: The disruptions wrought by COVID-19 have spurred the development of vaccines at a pace unprecedented in global history. We have witnessed vaccine development from in vivo testing to population-wide implementation in just under 1 year. Singapore’s vaccination rate of 80%, attained at the start of September 2021, marks a milestone. It signals that plans to shift from a “zero transmission” approach to an endemic “living with COVID-19” approach is headed in the right direction, albeit cautiously and with some uncertainty. Although we ask ourselves at what rate our society should be reopened, we acknowledge that such questions are not easily answered because newer variants are proving more transmissible and, possibly, vaccine resistant compared to earlier variants. Methods: COVID-19 vaccination milestones were plotted. A timeline was used to map key events of Singapore’s vaccination strategy in terms of legislation, logistics and operations, vaccination eligibility, vaccination sites, and measures implemented to encourage vaccine uptake. These factors were compared with Singapore’s vaccination rate from December 2020 to early September 2021. Results: The successful vaccination strategy in Singapore has been explored in 4 main areas: good leadership and evidence-based decision making, use of communications, utilizing existing logistics, and an ever-ready primary care. Conclusions: As we transition to our second year of combating COVID-19, emerging variants, spread despite vaccination, and the contesting voices of antivaxxers pose new challenges. Vaccine-generated immunity is only one, albeit an important, element of a comprehensive COVID-19 strategy. The strategy must also entail surveillance, self-testing, contact tracing, quarantine, legislation, financial support, and strengthened social responsibility. As providers of vaccination and translators of upstream evidence and policy decisions in the community, primary care providers should be involved early in decision making regarding interventions in the community because they can foresee challenges on the ground. Let us put our continued trust in primary care providers to contribute to making Singapore a COVID-19–resilient nation.
format Online
Article
Text
id pubmed-10571223
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-105712232023-10-14 SG-APSIC1027: COVID-19 vaccination strategy in Singapore—Perspectives and lessons from primary care Koh, Sky Wei Chee Keong, Victor Loh Weng Yiyang, Liow Kit, Leong Choon Young, Doris Antimicrob Steward Healthc Epidemiol Covid-19 Objectives: The disruptions wrought by COVID-19 have spurred the development of vaccines at a pace unprecedented in global history. We have witnessed vaccine development from in vivo testing to population-wide implementation in just under 1 year. Singapore’s vaccination rate of 80%, attained at the start of September 2021, marks a milestone. It signals that plans to shift from a “zero transmission” approach to an endemic “living with COVID-19” approach is headed in the right direction, albeit cautiously and with some uncertainty. Although we ask ourselves at what rate our society should be reopened, we acknowledge that such questions are not easily answered because newer variants are proving more transmissible and, possibly, vaccine resistant compared to earlier variants. Methods: COVID-19 vaccination milestones were plotted. A timeline was used to map key events of Singapore’s vaccination strategy in terms of legislation, logistics and operations, vaccination eligibility, vaccination sites, and measures implemented to encourage vaccine uptake. These factors were compared with Singapore’s vaccination rate from December 2020 to early September 2021. Results: The successful vaccination strategy in Singapore has been explored in 4 main areas: good leadership and evidence-based decision making, use of communications, utilizing existing logistics, and an ever-ready primary care. Conclusions: As we transition to our second year of combating COVID-19, emerging variants, spread despite vaccination, and the contesting voices of antivaxxers pose new challenges. Vaccine-generated immunity is only one, albeit an important, element of a comprehensive COVID-19 strategy. The strategy must also entail surveillance, self-testing, contact tracing, quarantine, legislation, financial support, and strengthened social responsibility. As providers of vaccination and translators of upstream evidence and policy decisions in the community, primary care providers should be involved early in decision making regarding interventions in the community because they can foresee challenges on the ground. Let us put our continued trust in primary care providers to contribute to making Singapore a COVID-19–resilient nation. Cambridge University Press 2023-03-16 /pmc/articles/PMC10571223/ http://dx.doi.org/10.1017/ash.2023.26 Text en © The Society for Healthcare Epidemiology of America 2023 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Covid-19
Koh, Sky Wei Chee
Keong, Victor Loh Weng
Yiyang, Liow
Kit, Leong Choon
Young, Doris
SG-APSIC1027: COVID-19 vaccination strategy in Singapore—Perspectives and lessons from primary care
title SG-APSIC1027: COVID-19 vaccination strategy in Singapore—Perspectives and lessons from primary care
title_full SG-APSIC1027: COVID-19 vaccination strategy in Singapore—Perspectives and lessons from primary care
title_fullStr SG-APSIC1027: COVID-19 vaccination strategy in Singapore—Perspectives and lessons from primary care
title_full_unstemmed SG-APSIC1027: COVID-19 vaccination strategy in Singapore—Perspectives and lessons from primary care
title_short SG-APSIC1027: COVID-19 vaccination strategy in Singapore—Perspectives and lessons from primary care
title_sort sg-apsic1027: covid-19 vaccination strategy in singapore—perspectives and lessons from primary care
topic Covid-19
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571223/
http://dx.doi.org/10.1017/ash.2023.26
work_keys_str_mv AT kohskyweichee sgapsic1027covid19vaccinationstrategyinsingaporeperspectivesandlessonsfromprimarycare
AT keongvictorlohweng sgapsic1027covid19vaccinationstrategyinsingaporeperspectivesandlessonsfromprimarycare
AT yiyangliow sgapsic1027covid19vaccinationstrategyinsingaporeperspectivesandlessonsfromprimarycare
AT kitleongchoon sgapsic1027covid19vaccinationstrategyinsingaporeperspectivesandlessonsfromprimarycare
AT youngdoris sgapsic1027covid19vaccinationstrategyinsingaporeperspectivesandlessonsfromprimarycare